Xie Ashleigh, Lo Phillip, Yan Tristan D, Forrest Paul
The Collaborative Research Group, Macquarie University, Sydney, Australia; University of New South Wales, Sydney, Australia.
The Collaborative Research Group, Macquarie University, Sydney, Australia; Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
J Cardiothorac Vasc Anesth. 2017 Oct;31(5):1836-1846. doi: 10.1053/j.jvca.2017.03.001. Epub 2017 Mar 2.
To review the evidence on neurologic complications in adult extracorporeal membrane oxygenation (ECMO) patients with regard to incidence, pathophysiology, risk factors, diagnosis, monitoring techniques, prevention, and management.
Literature review.
Observational studies and case reports from a variety of institutions.
Adult ECMO patients.
Six electronic databases were searched from their dates of inception to October 2016.
The range of neurologic complications reported in adult ECMO patients included stroke, intracranial hemorrhage, and brain death. Due to a lack of standardized reporting, their true incidence may have been underestimated significantly. A variety of pathophysiologic mechanisms and risk factors have been proposed. Some of these are specific to venoarterial ECMO, whereas others may be more relevant to venovenous ECMO (eg, rapid correction of hypercarbia). With regard to diagnosis and monitoring, clinical examination alone can be challenging and insufficiently sensitive, particularly for the confirmation of brain death. Computed tomography is the main imaging modality for acute neurologic assessment because magnetic resonance imaging is not feasible in these patients. Options for neuromonitoring are limited, although cerebral near-infrared spectroscopy may be useful. There are very limited data to guide the management of specific complications such as intracranial hemorrhage, which remains a leading cause of mortality in ECMO patients.
ECMO can be lifesaving and is being used increasingly for severe respiratory and/or cardiac failure. However, it remains associated with significant neurologic morbidity and mortality. Greater research clearly is needed to determine the best approach to the assessment and management of neurologic complications in this rapidly growing patient population.
回顾有关成人体外膜肺氧合(ECMO)患者神经并发症的发生率、病理生理学、危险因素、诊断、监测技术、预防及管理方面的证据。
文献综述。
来自各种机构的观察性研究和病例报告。
成人体外膜肺氧合患者。
检索了6个电子数据库,检索时间从建库至2016年10月。
成人体外膜肺氧合患者报告的神经并发症范围包括中风、颅内出血和脑死亡。由于缺乏标准化报告,其真实发生率可能被显著低估。已提出多种病理生理机制和危险因素。其中一些特定于静脉-动脉体外膜肺氧合,而其他一些可能与静脉-静脉体外膜肺氧合更相关(例如,高碳酸血症的快速纠正)。关于诊断和监测,仅靠临床检查具有挑战性且敏感性不足,尤其是对于脑死亡的确认。计算机断层扫描是急性神经评估的主要成像方式,因为磁共振成像在这些患者中不可行。神经监测的选择有限,尽管脑近红外光谱可能有用。指导颅内出血等特定并发症管理的数据非常有限,颅内出血仍然是体外膜肺氧合患者死亡的主要原因。
体外膜肺氧合可挽救生命,并且越来越多地用于严重呼吸和/或心力衰竭。然而,它仍然与显著的神经发病率和死亡率相关。显然需要更多研究来确定在这一快速增长的患者群体中评估和管理神经并发症的最佳方法。